Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Retained Earnings: 2022-2024

Historic Retained Earnings for Gossamer Bio (GOSS) over the last 3 years, with Dec 2024 value amounting to -$1.3 billion.

  • Gossamer Bio's Retained Earnings fell 12.64% to -$1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.4 billion, marking a year-over-year decrease of 12.64%. This contributed to the annual value of -$1.3 billion for FY2024, which is 4.66% down from last year.
  • According to the latest figures from FY2024, Gossamer Bio's Retained Earnings is -$1.3 billion, which was down 4.66% from -$1.2 billion recorded in FY2023.
  • In the past 5 years, Gossamer Bio's Retained Earnings registered a high of -$1.0 billion during FY2022, and its lowest value of -$1.3 billion during FY2024.
  • Moreover, its 3-year median value for Retained Earnings was -$1.2 billion (2023), whereas its average is -$1.2 billion.
  • Data for Gossamer Bio's Retained Earnings shows a maximum YoY fell of 17.42% (in 2023) over the last 5 years.
  • Yearly analysis of 3 years shows Gossamer Bio's Retained Earnings stood at -$1.0 billion in 2022, then declined by 17.42% to -$1.2 billion in 2023, then fell by 4.66% to -$1.3 billion in 2024.